Stertz L, Magalhes PVS, Kapczinski F
While more equine-specific studies are needed, it is sometimes used as a nutritional aid in breeding programs under veterinary supervision
The active ingredient semaglutide has been studied in over 20 clinical trials involving more than 14,000 patients
In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future
Obes Rev (2022) 23(6):e13435
BPC-157 for IBS & Leaky Gut BPC-157 may help: Restore intestinal barrier integrity Reduce inflammation in the gut lining Normalize abnormal gut motility Support the enteric nervous system Such effects are highly relevant for Irritable Bowel Syndrome (IBS), bloating, and leaky gut conditions